▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #781 by analyst upside · 2026-11-09
ATNM
Actinium Pharmaceuticals, Inc.
Healthcare · Market Cap $45M · P/E 4.0x
ANALYST PRICE TARGET
+179.7%
implied upside to consensus target
Current Price $1.43
Consensus Target $4.0
Bull Target $5.0
Bear Target $3.0
Analysts Covering 4
ANALYST CONSENSUS - BUY
Strong Buy
1
Buy
3
Hold
0
Sell
0
52-Week Low $0.73
52-Week High $1.72
YTD Return +4.4%
FUNDAMENTALS
Market Cap $45M
P/E Ratio (TTM) 4.0x
Forward P/E N/A
EPS (TTM) $0.36
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $35M
Profit Margin 32.2%
52-WEEK RANGE
52-Week Low $0.73
52-Week High $1.72
Current Price $1.43
Bear Target $3.0
Bull Target $5.0
● Now $1.43 ● Target $4.0
TRADING DATA
Avg Volume 184K
YTD Return +4.4%
Analyst Count 4
Consensus Buy
Upside to Target +179.7%
Last Updated 2026-11-09

ANALYST SUMMARY

Actinium Pharmaceuticals, Inc. (ATNM) is currently trading at $1.43 with a Wall Street consensus price target of $4.0, implying potential upside of 179.7% over the next 12 months. 4 analysts currently cover ATNM, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $5.0, while the most cautious has a target of $3.0.

ATNM operates in the Healthcare sector with a market capitalisation of $45M. The stock is up 4.4% year-to-date and is currently trading near the upper end of its 52-week range of $0.73 – $1.72.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for ATNM, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Stephens & Co. reit
Overweight → Overweight 2026-03-31 Building track record
HC Wainwright & Co. reit
Buy → Buy 2025-06-24 31% win rate (48 calls)
HC Wainwright & Co. reit
Buy → Buy 2025-05-12 31% win rate (48 calls)
HC Wainwright & Co. reit
Buy → Buy 2025-04-28 31% win rate (48 calls)
HC Wainwright & Co. reit
Buy → Buy 2025-04-01 31% win rate (48 calls)
HC Wainwright & Co. reit
Buy → Buy 2025-03-27 31% win rate (48 calls)
HC Wainwright & Co. reit
Buy → Buy 2025-03-25 31% win rate (48 calls)
HC Wainwright & Co. reit
Buy → Buy 2025-03-20 31% win rate (48 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
41
out of 100
Coverage depth
12/30
Consensus clarity
2/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →